A Randomized Clinical Trial of Allopregnanolone for the Treatment of Severe Traumatic Brain Injury
Abstract
There is a strong experimental support fo the concept that allopregnanolone will be safe and have beneficial effects on disability when administered as a treatment following acute traumatic brain injury (TBI). This study will provide initial data on the safety and effectiveness of allopregnanolone in improving neurobehavioral outcome and reducing mortality in adults with moderate and severe TBI.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2012
- Accession Number
- ADA592941
Entities
People
- Michael A. Rogawski
Organizations
- University of California